Safety of Blood and Plasma Derivatives: Pathogen Reducing Technologies
Human blood and blood products is the source of a wide range of medicinal products used for the treatment and prevention of a variety of injuries and disease. Despite stringent routine measures and filters employed, residual pathogen infectivity remains an important challenge in the field of blood t...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Iran University of Medical Sciences
2006-07-01
|
| Series: | Medical Journal of The Islamic Republic of Iran |
| Subjects: | |
| Online Access: | http://mjiri.tums.ac.ir/browse.php?a_code=A-10-1-214&slc_lang=en&sid=1 |
| id |
doaj-5431203fed124ae7884540cf02c79671 |
|---|---|
| record_format |
Article |
| spelling |
doaj-5431203fed124ae7884540cf02c796712020-11-24T23:22:30ZengIran University of Medical SciencesMedical Journal of The Islamic Republic of Iran1016-14302251-68402006-07-012028692Safety of Blood and Plasma Derivatives: Pathogen Reducing TechnologiesA. A. PourfathollahK. Mousavi HosseiniM. A. JaliliZ. MotallebiH. RezvanHuman blood and blood products is the source of a wide range of medicinal products used for the treatment and prevention of a variety of injuries and disease. Despite stringent routine measures and filters employed, residual pathogen infectivity remains an important challenge in the field of blood transfusion. In this article various measures and technologies that can be applied in order to reduce the residual risk are reviewed.http://mjiri.tums.ac.ir/browse.php?a_code=A-10-1-214&slc_lang=en&sid=1Plasma DerivativesVirus InactivationBlood Borne Viruses |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
A. A. Pourfathollah K. Mousavi Hosseini M. A. Jalili Z. Motallebi H. Rezvan |
| spellingShingle |
A. A. Pourfathollah K. Mousavi Hosseini M. A. Jalili Z. Motallebi H. Rezvan Safety of Blood and Plasma Derivatives: Pathogen Reducing Technologies Medical Journal of The Islamic Republic of Iran Plasma Derivatives Virus Inactivation Blood Borne Viruses |
| author_facet |
A. A. Pourfathollah K. Mousavi Hosseini M. A. Jalili Z. Motallebi H. Rezvan |
| author_sort |
A. A. Pourfathollah |
| title |
Safety of Blood and Plasma Derivatives: Pathogen Reducing Technologies |
| title_short |
Safety of Blood and Plasma Derivatives: Pathogen Reducing Technologies |
| title_full |
Safety of Blood and Plasma Derivatives: Pathogen Reducing Technologies |
| title_fullStr |
Safety of Blood and Plasma Derivatives: Pathogen Reducing Technologies |
| title_full_unstemmed |
Safety of Blood and Plasma Derivatives: Pathogen Reducing Technologies |
| title_sort |
safety of blood and plasma derivatives: pathogen reducing technologies |
| publisher |
Iran University of Medical Sciences |
| series |
Medical Journal of The Islamic Republic of Iran |
| issn |
1016-1430 2251-6840 |
| publishDate |
2006-07-01 |
| description |
Human blood and blood products is the source of a wide range of medicinal products used for the treatment and prevention of a variety of injuries and disease. Despite stringent routine measures and filters employed, residual pathogen infectivity remains an important challenge in the field of blood transfusion. In this article various measures and technologies that can be applied in order to reduce the residual risk are reviewed. |
| topic |
Plasma Derivatives Virus Inactivation Blood Borne Viruses |
| url |
http://mjiri.tums.ac.ir/browse.php?a_code=A-10-1-214&slc_lang=en&sid=1 |
| work_keys_str_mv |
AT aapourfathollah safetyofbloodandplasmaderivativespathogenreducingtechnologies AT kmousavihosseini safetyofbloodandplasmaderivativespathogenreducingtechnologies AT majalili safetyofbloodandplasmaderivativespathogenreducingtechnologies AT zmotallebi safetyofbloodandplasmaderivativespathogenreducingtechnologies AT hrezvan safetyofbloodandplasmaderivativespathogenreducingtechnologies |
| _version_ |
1725567844483072000 |